Bethany Sensenig
CIK 1899935 · Chief Financial Officer · last filed 2026-06-11
Bethany Sensenig is a Chief Financial Officer who has filed 13 SEC Form 4 insider transactions across 4 companies since 2022. The most recent filing, for KALV, was dated Jun 11, 2026. Across all open-market trades the lifetime net is −$466.1K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $32.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$32.9K
4
13
-$466.1K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KALV | Director | — | $27.00 | — | $0 | 2 | 2026-06-11 |
| ACOG | Director | 5,489 | $5.99 | $32.9K | $0 | 1 | 2026-04-17 |
| SUPN | Director | 0 | $44.41 | $0 | -$455.1K | 7 | 2026-02-23 |
| 9 METERS BIOPHARMA, INC. (NMTR) Delisted | Chief Financial Officer | 41,077 | $0.07 | $3.0K | -$11.0K | 3 | 2023-04-21 |
Recent Filings
13 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-11 | KALV | Disp (D) | — | $0 | EDGAR |
| 2026-04-17 | ACOG | Grant (A) | +5,489 | $0 | EDGAR |
| 2026-02-23 | SUPN | Mixed | — | -$228.3K | EDGAR |
| 2026-02-20 | SUPN | Grant (A) | — | $0 | EDGAR |
| 2025-10-02 | KALV | Grant (A) | — | $0 | EDGAR |
| 2025-08-18 | SUPN | Sell (S) | −5,369 | -$226.8K | EDGAR |
| 2025-02-24 | SUPN | Mixed | +5,369 | $0 | EDGAR |
| 2025-02-21 | SUPN | Grant (A) | — | $0 | EDGAR |
| 2024-02-26 | SUPN | Grant (A) | — | $0 | EDGAR |
| 2023-08-21 | SUPN | Grant (A) | — | $0 | EDGAR |